|

Tislelizumab Combined With Chemotherapy Clinical Trials

2 actively recruiting trials

Also known as: thoracic consolidation radiotherapy

Pipeline

Phase 2: 2

Top Sponsors

  • First Affiliated Hospital of Guangxi Medical University1
  • Chongqing University Cancer Hospital1

Indications

  • Cancer2
  • Rectal Cancer Stage III1
  • Rectal Cancer Stage II1
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)1
  • Rectal Cancer1

Other2 trials

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
Phase 2
Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.